Prudential Financial Inc Crinetics Pharmaceuticals, Inc. Transaction History
Prudential Financial Inc
- $70.8 Billion
- Q4 2024
A detailed history of Prudential Financial Inc transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 277,370 shares of CRNX stock, worth $9.21 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
277,370
Previous 172,786
60.53%
Holding current value
$9.21 Million
Previous $8.83 Million
60.69%
% of portfolio
0.02%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding CRNX
# of Institutions
254Shares Held
89.2MCall Options Held
26.1KPut Options Held
11.8K-
Vanguard Group Inc Valley Forge, PA9.09MShares$302 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA6.95MShares$231 Million0.07% of portfolio
-
Black Rock Inc. New York, NY6.23MShares$207 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.14MShares$204 Million3.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.41MShares$180 Million0.03% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $1.79B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...